Studies on faster and more sensitive methods for the detection of the COVID-19 (SARS-COV2) virus, which has spread widely around the world, continue with great intensity.
CoviX rapid scanning kits, produced by our company, will enable individuals to achieve much faster and more precise results. False negative rates increase significantly due to the fact that individuals withdraw themselves as a result of reflex while taking the swab sample and that the swab cannot reach the nasopharyngeal region.
In our CoviX kit, virus detection is made from saliva samples and we prevent this false negative situation. Our kit, in which we use the LAMP system instead of the existing qPCR-based kits, gives results in as little as 30 minutes.
It is aimed to prevent the increase of COVID-19 disease with the CoviX rapid screening kits, which can be delivered to more people faster, more sensitively, by increasing the accuracy in sampling, the ease of preparation of the experimental set and the LAMP system giving results in as little as 30 minutes.